SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • November 7th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 7th, 2019 Company Industry JurisdictionThis Separation Agreement and General Release (the “Agreement”) is entered into by and between Proteostasis Therapeutics, Inc. (the “Company”) and Po-Shun Lee (the “Executive” and, together with the Company, the “Parties”). This Agreement is effective as of the Effective Date, as defined below. Capitalized terms that are not otherwise defined in this Agreement shall have the meanings as defined in the Amended and Restated Employment Agreement dated October 21, 2016 between the Parties (the “Employment Agreement”).
Consulting AGREEMENTConsulting Agreement • November 7th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 7th, 2019 Company Industry JurisdictionThis Consulting Agreement (this "Agreement"), is entered into as of July 23, 2019 ("Effective Date") by and between (i) Proteostasis Therapeutics, Inc., a Delaware corporation with a business address of 80 Guest Street, Suite 500, Fifth Floor, Boston, Massachusetts 02135 (the "Company"), and (ii) Po-Shun Lee, an individual having an address of 28 Hallwell Road, Chestnut Hill, Massachusetts 02467 (the "Consultant").